Miquel Marquès-Camí

ORCID: 0000-0001-9827-041X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Gastrointestinal disorders and treatments
  • Gastrointestinal Bleeding Diagnosis and Treatment
  • Inflammatory Bowel Disease
  • Gastrointestinal Tumor Research and Treatment
  • Microscopic Colitis
  • Cardiac Arrest and Resuscitation
  • Palliative Care and End-of-Life Issues
  • Trauma and Emergency Care Studies
  • Vasculitis and related conditions
  • Health, Medicine and Society
  • Pharmacological Effects of Natural Compounds
  • Emergency and Acute Care Studies
  • Healthcare Decision-Making and Restraints
  • Trauma Management and Diagnosis
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Complement system in diseases
  • Injury Epidemiology and Prevention
  • Renal Diseases and Glomerulopathies
  • Eosinophilic Disorders and Syndromes
  • Abdominal vascular conditions and treatments
  • Cardiac, Anesthesia and Surgical Outcomes
  • Diagnosis and treatment of tuberculosis
  • Diverticular Disease and Complications
  • Traumatic Brain Injury and Neurovascular Disturbances
  • Pharmaceutical Practices and Patient Outcomes

Hospital Universitari Arnau de Vilanova
2021-2025

Biomedical Research Institute of Lleida
2025

Hospital Universitari de Santa Maria
2021

Vall d'Hebron Hospital Universitari
2020

Centre hospitalier régional d'Orléans
1994-1998

Abstract Background The terminal ileum stands out as the most frequently affected segment of gastrointestinal tract in Crohn’s disease (CD). However, ileocolonoscopy (IC) may occasionally fail to fully explore this area. Assessing inflammation activity only lead underestimating overall ileal involvement. Capsule endoscopy (CE) offers a complete examination both entire and proximal segment. Methods This study presents preliminary analysis an ongoing multicenter retrospective conducted at 16...

10.1093/ecco-jcc/jjae190.0609 article EN Journal of Crohn s and Colitis 2025-01-01

Abstract Background There are few data regarding the management on acute severe ulcerative colitis (ASUC) flare in patients with previous anti-TNF exposure. We evaluated medical management, risk of colectomy and factors associated comparing a bionaive cohort. Methods A retrospective multicentric study GETECCU. Patients ASUC episode between 2010-2020 were included two cohorts: bio-exposed (cohort 1) bio-naive 2). other biologics or JAK inhibitors exposure excluded. Steroid response was...

10.1093/ecco-jcc/jjad212.0952 article EN Journal of Crohn s and Colitis 2024-01-01

ustekinumab is a fully human monoclonal antibody against IL-12/23, approved for induction and maintenance treatment of Crohn's disease (CD). Real-life data shows its true effectiveness in terms clinical endoscopic response. However, there little information regarding health-related quality life (HRQoL) CD patients receiving ustekinumab. The main aim this study was to define long-term remission HRQoL normalization. predictive factors were investigated as secondary aim.a retrospective,...

10.17235/reed.2020.6941/2020 article EN publisher-specific-oa Revista Española de Enfermedades Digestivas 2020-01-01

Abstract Text Vasculitis has been reported as an odd autoinmune-related side effect of COVID-19 and its vaccination, associated to the virus’ affinity for ACE2 receptor on enterocytes. It can lead acute intestinal ischaemia. We report a case vaccine-related ischaemiae patient who presented with abdominal pain fever following vaccination progressed dynamic ileus enterorrhagia. The diagnose was achieved aid capsule endoscopy (showing submucosal hematomas, friability mucosal denudation)...

10.1055/s-0043-1765105 article EN Endoscopy 2023-04-01
Coming Soon ...